Cutaneous Squamous Cell Carcinoma is a Different Diagnosis From Head and Neck Squamous Cell Carcinoma

登录注册会员服务联系我们

Cutaneous Squamous Cell Carcinoma is a Different Diagnosis From Head and Neck Squamous Cell Carcinoma—Reply

Published:2024-09-01 Issue:9 Volume:150 Page:833
ISSN:2168-6181
Container-title:JAMA Otolaryngology–Head & Neck Surgery
language:en
Short-container-title:JAMA Otolaryngol Head Neck Surg

Author:

Corbett Mel¹,Ramli Ruzaimi¹,O’Duffy Fergal¹²³

Affiliation:

1. University College Dublin Head and Neck Oncology Group, Dublin, Ireland

2. Department of Head and Neck Surgery, Saint Vincent’s University Hospital, Dublin, Ireland

3. Department of Head and Neck Surgery, The Mater Misericordiae University Hospital, Dublin, Ireland

Publisher

American Medical Association (AMA)

Link

https://jamanetwork.com/journals/jamaotolaryngology/articlepdf/2821380/jamaotolaryngology_corbett_2024_lr_240008_1724860418.72506.pdf

Reference5 articles.

1. Clinical response with pembrolizumab for cutaneous squamous cell carcinoma.;Corbett;JAMA Otolaryngol Head Neck Surg,2024

2. Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: updated results of the phase III Keynote-048 study.;Harrington;J Clin Oncol,2023

3. Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial.;Migden;Lancet Oncol,2020

4. Neoadjuvant-intent immunotherapy in advanced, resectable cutaneous squamous cell carcinoma.;Kim;JAMA Otolaryngol Head Neck Surg,2024

5. Cemiplimab therapy. National Cancer Control Programme (NCCP). Accessed May 9, 2024. https://www.hse.ie/eng/services/list/5/cancer/profinfo/chemoprotocols/melanoma/812-cemiplimab-therapy.pdf

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP